$0.680
+0.001 (+0.15%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CLDI por análisis de gráficos similares
Alphio's CLDI stock price prediction model matches the current Calidi Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.69 (+0.98%). The 1-week path is $0.72 (+6.28%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Calidi Biotherapeutics Inc?
Calidi Biotherapeutics is not a good buy right now due to its severe financial losses and delisting risk. The stock has a current price of $0.68, down 96.40% year-to-date, and has a negative forward P/E ratio of 0, indicating no earnings expectations. Additionally, the company faces a compliance notice from the NYSE due to stockholders' equity below the required $4 million, which poses a significant risk of delisting.
CLDI cerró en $0.68 el Friday, tras subir +0.15%
Calidi Biotherapeutics Inc (CLDI) last closed at $0.68, gaining +0.15%. These facts feed the 1-day and 1-week CLDI price prediction above.
Factores de la previsión
Los factores de la previsión de Calidi Biotherapeutics Inc (CLDI) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CLDI, ordenadas por similitud.
Análisis de estacionalidad de CLDI
Historically the probability of a positive November return for CLDI is 0.00%. February offers the highest probability of a positive month at 20.69%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CLDI
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $0.45 | $0.53 | $0.62 | -22.09% |
| Dec 2026 | $0.53 | $0.63 | $0.72 | -7.44% |
En 2026, se proyecta que Calidi Biotherapeutics Inc (CLDI) oscile entre $0.45 y $0.72.
Previsión mensual de Calidi Biotherapeutics Inc para 2026
En Nov de 2026, se proyecta que Calidi Biotherapeutics Inc promedie $0.53, con un mínimo de $0.45 y un máximo de $0.62.
En Dec de 2026, se proyecta que Calidi Biotherapeutics Inc promedie $0.63, con un mínimo de $0.53 y un máximo de $0.72.
Artículos relacionados
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.